article · International Neurourology Journal

Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial

M. A. Elbaset
Mohamed H. Zahran
Ahmed S. El‐Hefnawy
Diaa‐Eldin Taha
Ahmed A. Shokeir

20198 citationsOpen accessKafr el-Sheikh University

Abstract

In patients with refractory idiopathic OAB, reuse of anticholinergics could be an effective treatment option in patients after the effects of BTX-A fade. Repeated intravesical BTX-A injections and increased cystometric capacity could affect treatment response.

Research topics

Urinary Bladder and Prostate Research
Pelvic floor disorders treatments
Gastroesophageal reflux and treatments

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.5213/inj.1938098.049

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.